These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19158842)

  • 1. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97.
    Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW
    J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major cleavage-dependent epitopes for linear IgA bullous dermatosis are formed at the boundary between the non-collagenous 16A and collagenous 15 domains of BP180.
    Yamauchi T; Matsushita S; Hashimoto T; Hirako Y
    J Dermatol Sci; 2014 Oct; 76(1):25-33. PubMed ID: 25176590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.
    Roh JY; Yee C; Lazarova Z; Hall RP; Yancey KB
    Br J Dermatol; 2000 Jul; 143(1):104-11. PubMed ID: 10886143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.
    Schumann H; Baetge J; Tasanen K; Wojnarowska F; Schäcke H; Zillikens D; Bruckner-Tuderman L
    Am J Pathol; 2000 Feb; 156(2):685-95. PubMed ID: 10666397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2.
    Zone JJ; Taylor TB; Meyer LJ; Petersen MJ
    J Invest Dermatol; 1998 Mar; 110(3):207-10. PubMed ID: 9506436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid.
    Verraes S; Hornebeck W; Polette M; Borradori L; Bernard P
    J Invest Dermatol; 2001 Nov; 117(5):1091-6. PubMed ID: 11710917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid.
    Nishie W; Lamer S; Schlosser A; Licarete E; Franzke CW; Hofmann SC; Jackow J; Sitaru C; Bruckner-Tuderman L
    J Immunol; 2010 Oct; 185(8):4938-47. PubMed ID: 20861347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen XVII/BP180: a collagenous transmembrane protein and component of the dermoepidermal anchoring complex.
    Powell AM; Sakuma-Oyama Y; Oyama N; Black MM
    Clin Exp Dermatol; 2005 Nov; 30(6):682-7. PubMed ID: 16197389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.
    Nishie W; Natsuga K; Iwata H; Izumi K; Ujiie H; Toyonaga E; Hata H; Nakamura H; Shimizu H
    Am J Pathol; 2015 May; 185(5):1361-71. PubMed ID: 25773176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.
    Kamaguchi M; Iwata H; Ujiie H; Natsuga K; Nishie W; Kitagawa Y; Shimizu H
    J Invest Dermatol; 2018 Aug; 138(8):1707-1715. PubMed ID: 29530535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180.
    Tashima S; Konishi K; Koga H; Hashimoto T
    Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of monoclonal antibodies against the intracellular domain of hemidesmosomal type XVII collagen.
    Olaru F; Mihai S; Petrescu I; Zillikens D; Sitaru C
    Hybridoma (Larchmt); 2006 Jun; 25(3):158-62. PubMed ID: 16796463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII.
    Zimina EP; Hofmann SC; Fritsch A; Kern JS; Sitaru C; Bruckner-Tuderman L
    J Invest Dermatol; 2008 Nov; 128(11):2736-2739. PubMed ID: 18548115
    [No Abstract]   [Full Text] [Related]  

  • 16. Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.
    Wada M; Nishie W; Ujiie H; Izumi K; Iwata H; Natsuga K; Nakamura H; Kitagawa Y; Shimizu H
    J Invest Dermatol; 2016 May; 136(5):938-946. PubMed ID: 26827765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-Terminal Processing of Collagen XVII Induces Neoepitopes for Linear IgA Dermatosis Autoantibodies.
    Toyonaga E; Nishie W; Izumi K; Natsuga K; Ujiie H; Iwata H; Yamagami J; Hirako Y; Sawamura D; Fujimoto W; Shimizu H
    J Invest Dermatol; 2017 Dec; 137(12):2552-2559. PubMed ID: 28842325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody BP180 against bullous pemphigoid antigen-2 type XVII collagen.
    Fairley JA
    Hybridoma (Larchmt); 2012 Apr; 31(2):146-7. PubMed ID: 22509921
    [No Abstract]   [Full Text] [Related]  

  • 19. Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.
    Nishie W
    Methods Mol Biol; 2013; 961():363-9. PubMed ID: 23325657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of bullous pemphigoid.
    Ujiie H; Nishie W; Shimizu H
    Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.